HMGB1 Improves Heart Function and Regeneration in Failing Hearts
Author Information
Author(s): Limana Federica, Esposito Grazia, D'Arcangelo Daniela, Di Carlo Anna, Romani Sveva, Melillo Guido, Mangoni Antonella, Bertolami Chiara, Pompilio Giulio, Germani Antonia, Capogrossi Maurizio C.
Primary Institution: Centro Cardiologico Monzino-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
Hypothesis
Does HMGB1 injection into chronically failing hearts improve cardiac function and regeneration?
Conclusion
HMGB1 injection into chronically failing hearts enhances left ventricular function and reduces remodeling, promoting cardiac regeneration.
Supporting Evidence
- HMGB1-treated mice showed a 23% reduction in left ventricular volume.
- HMGB1 treatment resulted in a 48% increase in infarcted wall thickness.
- Cardiac regeneration was evidenced by a two-fold increase in c-kit+ cell number.
Takeaway
Injecting a protein called HMGB1 into sick hearts helps them work better and grow new heart cells.
Methodology
Adult female mice underwent coronary artery ligation and were treated with HMGB1 or control; echocardiography and hemodynamic measurements were taken to assess heart function.
Potential Biases
Potential bias in the selection of treatment groups and measurement techniques.
Limitations
The study was conducted in a mouse model, which may not fully replicate human heart failure conditions.
Participant Demographics
Adult female C57 BL16 mice.
Statistical Information
P-Value
p<0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website